Category: Joint ventures/collaborations
-
Companies to Partner on Sustainable Synthetic Biochemicals
A producer of plant-based organic acids and a developer of synthetic bio-based materials and services are partnering on new sustainable industrial chemicals.
-
Neurons Identified, Stimulated for Spinal Cord Repair
Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation.
-
Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment.
-
Immunotherapy Start-Up Launches Collaboration, Raises $65M
A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors.
-
Start-Up to Manufacture, Supply Practical Radiation Drugs
A new company formed by a technology venture investor and the Mayo Clinic aims to produce and supply more readily available radiation drug therapies.
-
Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test
A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria.
-
Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Industry-Univ. Team Assessing Electronic Brain Biomarkers
A developer of software analyzing brain signals for neurological disease indicators is engaging medical researchers to help assess the software in real-world settings.
-
Trial to Assess Multi-Factor Blood Test for Cancer
A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings.